top of page

VIRAL Vs. NON-VIRAL GENETIC ENGINEERING OF T CELLS

Series in collaboration with the American Society of Gene & Cell Therapy




Combining Oncolytic Viruses and CAR-T Therapies

Saul Priceman,City of Hope, CA







Virus-free gene editing of T cells

Dimitrios Wagner, Berlin Center for Advanced Therapies (BeCAT), Charité - Universitätsmedizin Berlin, Germany






Considerations for engineering allogeneic cell therapies

Marco Alessandrini, Antion Bioscience






ความคิดเห็น


bottom of page